Our team consists of experienced business and regulatory executives and opinion leaders with unique insights into the development of neuropathy treatments and scientific experts with strong track records in the biopharmaceutical industry. We also retain a science and technology advisory team composed of renowned experts, industry veterans and arguably the leading key opinion leaders in neuropathy and biopharmaceuticals. We are rigorously pursuing a science-driven approach to translational medicine and clinical development.